Practical implementation of automated closed-loop insulin delivery: a French position statement.
暂无分享,去创建一个
G. Charpentier | E. Renard | A. Farret | J. Place | A. Penfornis | C. Thivolet | M. Joubert | Y. Reznik | E. Bismuth | B. Guerci | N. Jeandidier | S. Franc | V. Melki | L. Chaillous | H. Hanaire | P. Benhamou | R. Leroy | J. Riveline | P. Schaepelynck | A. Sola-Gazagnes | N. Tubiana-Rufi | D. Durain | P. Serusclat | B. Delemer | S. Borot | S. Lablanche | I. Guilhem | S. Picard | J. Beltrand | É. Bonnemaison | C. Abettan | A. Desserprix | N. Filhol | C. Guillot | M. Munch | Marion Munch | Sfd Paramedical Sfe Sfedp Ajd Ffd Fenarediam Sfd | Cnp-Edn | E. Bonnemaison
[1] Roman Hovorka,et al. Training and Support for Hybrid Closed-Loop Therapy , 2020, Journal of diabetes science and technology.
[2] R. Beck,et al. A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. , 2020, The New England journal of medicine.
[3] Jessie J Wong,et al. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets. , 2020, Diabetes technology & therapeutics.
[4] Janet M. Allen,et al. Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol , 2020, BMJ Open.
[5] R. Slover,et al. A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic , 2020, Journal of diabetes science and technology.
[6] Janet M. Allen,et al. What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial , 2020, Diabetes technology & therapeutics.
[7] A. Haidar,et al. A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial , 2020, Diabetes Care.
[8] R. Hovorka,et al. Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England , 2020, Diabetes technology & therapeutics.
[9] B. Anderson,et al. “I'm essentially his pancreas”: Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes , 2019, Pediatric diabetes.
[10] Eyal Dassau,et al. Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. , 2019, The New England journal of medicine.
[11] R. Hovorka,et al. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis. , 2019, Kidney international.
[12] R. Hovorka,et al. The importance of prandial insulin bolus timing with hybrid closed‐loop systems , 2019, Diabetic medicine : a journal of the British Diabetic Association.
[13] Gregory P. Forlenza,et al. A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. , 2019, Diabetes technology & therapeutics.
[14] Alissa J. Roberts,et al. Efficacy and Safety of Real Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old. , 2019, Diabetes technology & therapeutics.
[15] F. Doyle,et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range , 2019, Diabetes Care.
[16] M. Ladouceur,et al. Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial , 2019, Diabetes Care.
[17] Janet M. Allen,et al. Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery , 2019, Diabetes Care.
[18] N. Séjourné,et al. Revue de la littérature relative au burnout parental. , 2019, Canadian Psychology/Psychologie canadienne.
[19] Pierre Jallon,et al. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. , 2019, The Lancet. Digital health.
[20] David M Maahs,et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. , 2019, Diabetes technology & therapeutics.
[21] Janet M. Allen,et al. Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial , 2019, Diabetes Care.
[22] B. Buckingham,et al. Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes , 2019, Diabetes technology & therapeutics.
[23] D. Maahs,et al. ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes , 2018, Pediatric diabetes.
[24] Janet M. Allen,et al. Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial , 2018, The Lancet.
[25] R. Wadwa,et al. Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field , 2018, Current Diabetes Reports.
[26] L. Heinemann,et al. Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project , 2018, Journal of diabetes science and technology.
[27] A. Hattersley,et al. Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study , 2018, The Lancet.
[28] Roman Hovorka,et al. Closed‐Loop Insulin Delivery for Glycemic Control in Noncritical Care , 2018, The New England journal of medicine.
[29] R. Hovorka,et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis , 2018, British Medical Journal.
[30] R. Hovorka,et al. Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial , 2018, Diabetes Care.
[31] LazaroCaterina,et al. Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System , 2018 .
[32] Lori M Laffel,et al. Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes , 2018, Pediatric diabetes.
[33] Eyal Dassau,et al. Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas , 2018, Journal of Diabetes Science and Technology.
[34] Eyal Dassau,et al. Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study , 2017, Diabetes, obesity & metabolism.
[35] G. Charpentier,et al. Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement. , 2017, Diabetes & Metabolism.
[36] B. Perkins,et al. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. , 2017, The lancet. Diabetes & endocrinology.
[37] Ali Cinar,et al. Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System , 2017, Sensors.
[38] Benyamin Grosman,et al. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes , 2017, Diabetes technology & therapeutics.
[39] Roman Hovorka,et al. Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. , 2017, The lancet. Diabetes & endocrinology.
[40] R. Hovorka,et al. Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist , 2017, BMC Medicine.
[41] Roman Hovorka,et al. Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. , 2016, The New England journal of medicine.
[42] F. Doyle,et al. Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.
[43] Janet M. Allen,et al. Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study , 2014, Diabetes Care.
[44] K. Reynolds,et al. Insulin regimens and clinical outcomes in a type 1 diabetes cohort: The SEARCH for Diabetes in Youth study , 2014 .
[45] E. Renard,et al. When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. , 2010, Diabetes & metabolism.
[46] G. Chrousos,et al. Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis. , 2019, Metabolism: clinical and experimental.
[47] Y. Jang,et al. Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .